In this second segment of Bob Proulx’s presentation to investors at the 2016 NobleCon meeting, he answers the question of how magnetic relaxometry might be used in cancer medicine. This video introduces roles for magnetic relaxometry in early cancer detection, cancer staging, and therapeutic monitoring. It also outlines the unique capabilities of magnetic relaxometry relative to MRI, ultrasound, X-ray imaging, blood biomarkers, and biopsies.
Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer
MELBOURNE – Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce